According to ChemAnalyst, The Clindamycin Phosphate prices witnessed an upward trajectory across major global markets during the first quarter of 2026, supported by rising manufacturing costs, changing macroeconomic conditions, and resilient pharmaceutical demand. Clindamycin Phosphate, an essential antibiotic active pharmaceutical ingredient (API) widely used in topical formulations, injectable medications, and oral antibiotics, remained a strategically important product for
